Supplementary Figure S1 from Molecular Characterization of Residual Muscle-Invasive Bladder Cancer Identifies a Scar-Like Transcriptomic Profile with Favorable Prognosis after Neoadjuvant Therapy | AMiner
Supplementary Figure S1 from Molecular Characterization of Residual Muscle-Invasive Bladder Cancer Identifies a Scar-Like Transcriptomic Profile with Favorable Prognosis after Neoadjuvant Therapy
Figure S1. Disease Free Survival Outcomes for N = 84 TURBT cases from the ABACUS trial subtyped by Lund (A), Consensus (B) and TCGA (C) subtyping models.
原文链接
分享
引用
